Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1872
https://www.valueinhealthjournal.com/article/S1098-3015(16)33238-7/fulltext
Title :
Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33238-7&doi=10.1016/j.jval.2016.09.1872
First page :
A672
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1769